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Background: Many modern smart watches and activity trackers feature an optical sensor that estimates the wearer’s heart rate.
Recent studies have evaluated the performance of these consumer devices in the laboratory.
Objective: The objective of our study was to examine the accuracy and sensitivity of a common wrist-worn tracker device in
measuring heart rates and detecting 1-min bouts of moderate to vigorous physical activity (MVPA) under free-living conditions.
Methods: Ten healthy volunteers were recruited from a large university in Singapore to participate in a limited field test, followed
by a month of continuous data collection. During the field test, each participant would wear one Fitbit Charge HR activity tracker
and one Polar H6 heart rate monitor. Fitbit measures were accessed at 1-min intervals, while Polar readings were available for
10-s intervals. We derived intraclass correlation coefficients (ICCs) for individual participants comparing heart rate estimates.
We applied Centers for Disease Control and Prevention heart rate zone cut-offs to ascertain the sensitivity and specificity of Fitbit
in identifying 1-min epochs falling into MVPA heart rate zone.
Results: We collected paired heart rate data for 2509 1-min epochs in 10 individuals under free-living conditions of 3 to 6 hours.
The overall ICC comparing 1-min Fitbit measures with average 10-s Polar H6 measures for the same epoch was .83 (95% CI
.63-.91). On average, the Fitbit tracker underestimated heart rate measures by −5.96 bpm (standard error, SE=0.18). At the low
intensity heart rate zone, the underestimate was smaller at −4.22 bpm (SE=0.15). This underestimate grew to −16.2 bpm (SE=0.74)
in the MVPA heart rate zone. Fitbit devices detected 52.9% (192/363) of MVPA heart rate zone epochs correctly. Positive and
negative predictive values were 86.1% (192/223) and 92.52% (2115/2286), respectively. During subsequent 1 month of continuous
data collection (270 person-days), only 3.9% of 1-min epochs could be categorized as MVPA according to heart rate zones. This
measure was affected by decreasing wear time and adherence over the period of follow-up.
Conclusions: Under free-living conditions, Fitbit trackers are affected by significant systematic errors. Improvements in tracker
accuracy and sensitivity when measuring MVPA are required before they can be considered for use in the context of exercise
prescription to promote better health.
(JMIR Mhealth Uhealth 2017;5(10):e157)   doi:10.2196/mhealth.8233
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Sedentary behavior, daily step counts, and moderate to vigorous
physical activity (MVPA) have been identified as targets for
public health intervention [1]. In response to these findings, the
practice of physician-directed exercise prescription emerged as
a promising strategy to promote the health benefits of physical
activity. Under the tagline Exercise Is Medicine, clinicians are
advocating nonpharmacological interventions in the management
of chronic health conditions such as hypertension and diabetes
[2].
The objective of exercise prescription is to assess current levels
of activity and guide patients as they increase their levels of
exercise. A total of 150 min of MVPA per week is required to
sustain health, whereas 300 min is needed to improve health
[3]. It is rare for any information on physical activity to be
captured in clinical practice, and when patients are assessed for
their level of activity, little emphasis is placed on objective
measures. In the domain of population research, physical activity
questionnaires have for many years been the primary means of
measurement [4,5], although more recent studies have used
wearable devices to assess activity [6,7].
Today, objective measurement of individual physical activity
under free-living conditions has become a reality following the
introduction of miniaturized step counters and triaxial
accelerometer technology. What started off as ball-in-a-box
devices that were clipped to the belt have evolved into sleek
wrist-worn gadgets that connect wirelessly to mobile phones
and the Internet. Data are captured, logged, analyzed, and
displayed within a matter of seconds. Wearable devices, which
once had only been used in research settings, are now being
marketed directly to consumers on a large scale. A recent
systematic review of 22 studies has demonstrated high validity
of step count measures among commercial devices [8]. Our own
experience has shown remarkable correlation between
wrist-worn step counters and scientific devices under free-living
conditions [9]. It therefore follows that health care providers
and exercise professionals might learn to review and interpret
the large amounts of objective physical activity data that patients
and clients may have collected incidentally.
Apart from recording daily step counts or total volumes of
physical activity, a number of commercial wrist-worn trackers
and hybrid watches feature optical sensors that estimate heart
rates by means of photoplethysmography. The noninvasive
optical probe detects the small variation in light absorption
brought about by pulsatile perfusion of tissues [10]. In principle,
heart rate measures should offer a number of advantages in
activity tracking. First, heart rate monitors outperform
accelerometers in capturing non–weight-bearing activities such
as cycling and rowing. Second, whereas the latter reflects total
volume of activity, heart rate monitors provide information on
the relative intensity of activity, allowing MVPA to be more
accurately discerned from light activity. Finally, where
information on real-time relative intensity is available, there
are, in theory, potential applications in the realm of safety
monitoring for users at risk of overtraining [11]. The current
approach to intensity assessment still relies on tactile carotid or
radial pulse rates, a method which is potentially cumbersome
or inaccurate in laypersons.
Naturally, there are some important disadvantages using heart
rates to approximate physical activity. Heart rate is a vital sign
which responds to a multitude of physiological stimuli, including
emotional state and illness. Heart rates also tend to exhibit
considerable lag in the minutes following the cessation of
activity. Moreover, devices that have been shown to track heart
rates reliably, such as Polar [12,13] and Actiheart [14,15], by
measuring myocardial electric potentials (akin to an
electrocardiogram), are cumbersome to wear over extended
periods as they need to be strapped across the chest.
We sought to explore whether it would be feasible to adopt a
wrist-worn consumer wearable to augment health promotion
strategies such as exercise prescription. By monitoring heart
rate information through the wearable device, the patient would
have a more convenient means to guide the calibration of
intensity to attain a specific training target [11]. In turn, these
measures could be useful to review compliance during follow-up
appointments with the health care provider and make available
objective feedback to inform behavior change strategies [16].
The literature offers conflicting information on the utility of
wrist-worn heart rate sensors when tested for validity while
participating in exercise protocols under laboratory conditions.
Authors who chose to cite strong correlation coefficients and
low mean percentage errors as validation criteria concluded that
wrist-worn devices performed well [17-19]. Others with a
stricter definition of accuracy choosing to examine mean bias
and levels of agreement [20] concluded that devices performed
inadequately. When validated in hospital patients, the devices
were found suitable for a subset of patients who were in sinus
rhythm [21]. We found only a limited number of validation
studies that collected information on minute-by-minute heart
rates [22] and daily energy expenditure [23] outside the
laboratory. In the time following our data collection efforts, a
class action lawsuit was filed against Fitbit Inc, alleging that
the devices “consistently mis-record heart rates by a very
significant margin, particularly during exercise” [24].
To address some of the existing gaps in the literature, we have
conducted this validation study to assess the accuracy of a
common wrist-worn heart rate tracking device under free-living
conditions and to evaluate the feasibility of including heart rate
tracking measures as part of population-based activity
monitoring and mobile health interventions.
Methods
Participants
We aimed to recruit 40 members of the university’s staff and
students through department-approved internal emails for a pilot
study assessing the feasibility of wearable-based observational
studies examining physical activity, nutrition, and mental
well-being. Out of this pilot study group, a convenience sample
of 10 participants would be invited to participate in an additional
validation component to examine the accuracy of heart rate
measures provided by Fitbit Charge HR (Fitbit, San Francisco
CA, USA). Participants could be included if they owned a
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compatible mobile phone with a data plan, were aged between
18 and 65 years, and were unlikely to travel abroad over the
subsequent 1 month. The following criteria excluded an
interested participant from the study: having a severe medical
condition that would prevent participation in physical activity,
discomfort, or unwillingness to wear multiple devices
concurrently and participation in activities or work that would
restrict the use of the devices.
Study Procedures and Data Collection
We compiled baseline characteristics for all our participants by
means of a self-administered questionnaire. Measures of height
and weight were taken using a SECA stadiometer (SECA
GmbH, Hamburg, Germany) at our study site.
Each participant was provided a new Fitbit Charge HR (Fitbit)
tracker to be worn on the nondominant hand throughout the
pilot study. Participants were instructed in the use of the tracker
device and the installation of mobile phone apps according to
manufacturer’s specifications. They were also taught to
synchronize the Fitbit tracker periodically.
Each of the 10 participants in the heart rate validation series
were also fitted with one Polar H6 heart rate monitor (Polar
Electro Oy, Kempele, Finland) worn across the chest. To record
the Polar H6 heart rate monitor (Polar) data, these participants
were provided with an Actigraph GT3X+ logger (Actigraph)
on Bluetooth receiver mode set to sample measures at 10-s
intervals and worn on the same wrist as the Fitbit device. The
10 participants were asked to wear all 3 devices for at least 3
and at most 6 continuous hours of nonsleeping activities. They
were encouraged to continue pursuing their usual activities,
excluding water sports. The Polar and wrist-worn Actigraph
devices could be removed before bedtime and returned to the
study site over the following days. Participants would continue
to use their Fitbit trackers for the remaining 1 month of
free-living study. Participants used their personal data plans to
run synchronizations with the Fitbit server.
Fitbit heart rate measures were downloaded directly from the
Web server using a developer’s application programming
interface (API) issued by Fitbit. Polar measures were collated
from the wrist-worn Actigraph devices. Common wear time for
the validation study was defined as every 1-min epoch, which
reflected a nonzero heart rate on both devices. For the 1-month
period of continuous monitoring, any nonzero heart rate
registered by the Fitbit was defined as valid 1-min epoch of
wear time. A valid day of wear time was defined as having at
least 600 1-min epochs of nonzero counts within 1 calendar
day.
Graphical Analysis
Our first dataset comprised one Fitbit heart rate measure for
each discreet 1-min epoch, whereas six 10-s measures for the
same epoch were available from the Polar device. While the
Fitbit API allowed us to review heart rate measures at intervals
less than 1 min, the time differences between measures were
irregular. Given that Fitbit users would only have access to data
logs recorded by minute, we did not attempt to generate our
own summary measures for within-minute heart rates. It is worth
noting that the literature recommend that photoplethysmographic
readings should be averaged over a 60-s duration to obtain a
reliable measure [10]. To appreciate the data contributed by
individual participants, we generated time series plots of discreet
1-min epochs where Fitbit measures were superimposed onto
ranges of Polar 10-s measures. Thereafter, 10-s Polar heart rate
measures were averaged for each 1-min epoch. Subsequently,
we rank-ordered aggregated discreet epochs by their average
Polar measure, divided these epochs by deciles, and constructed
box plots to compare average Polar and Fitbit measures. Box
plots for the width of within-epoch ranges of 10-s Polar
measures were included in this descriptive plot.
Statistical Analysis
Intraclass correlation coefficients (ICCs) were calculated using
a mixed effects model assessing for absolute agreement between
average 10-s Polar measures, and 1-min Fitbit measures. ICCs
were calculated first for overall measures and then for measures
stratified by physical activity heart rate zone cut-offs proposed
by the Centers for Disease Control and Prevention [25] and by
individual participants. Given that the Polar device was chosen
as reference, heart rate zones were assigned according to each
participant’s age and average 10-s Polar measure within discreet
epochs. Two Bland-Altman plots were constructed to visually
evaluate the overall differences in absolute measures within
heart rate zones. A two-by-two table was constructed to estimate
the sensitivity, specificity, and positive and negative predictive
values for Fitbit devices, correctly identifying MVPA heart rate
zones where average 10-s Polar values were considered as
reference.
In our second dataset, we compiled all Fitbit heart rate measures
obtained in the 1-month free-living study period. The aggregated
valid days and epochs of wear time were compiled in a bar chart
with superimposed dot and whiskers plots. We tabulated
summary statistics for each participant, detailing the number of
1-min epochs spent in respective heart rate zones under
free-living conditions.
All statistical analyses were conducted using STATA (Version
13.1, StataCorp LP). Given the exploratory nature of this study,
P<.05 was chosen as a level of statistical significance. The
strength of ICC coefficients was interpreted based on the
following definitions: weak (r<.5), moderate (.5-.7), and strong
(r>.7). This study was approved by the institutional review
board of the National University of Singapore.
Results
Study Participants
From our pilot study group of 20 males and 20 females, we
recruited 3 females and 7 males to participate in the heart rate
validation segment. Recruitment and data collection began on
November 4, 2015, and the last day of assessment was January
7, 2016. Nine out of 10 participants were students, and their
average body mass index was 22.9 kg/m2 (standard deviation
[SD] 3.8). Table 1 describes the characteristics of the final
sample of 10 study participants.
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25.4 (3.7)Age in years, mean (SDa)
22.9 (3.8)Body mass index in kg/m2, mean (SD)
Number of valid 1-min epochs contributed, mean (SD)
250 (95)Paired measures
38880 (11758)1-month follow-up period
aSD: standard deviation.
Figure 1. Time-series of Fitbit 1-min measures (circles) and Polar 1-min ranges (gray bars) estimating heart rate in beats per minute for participants
D and I.
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Validation of Fitbit Measures Compared With Polar
Of a total of 2769 possible 1-min epochs, 2509 valid paired
readings were identified, with each participant contributing on
average 250 (SD 95) epochs. Unpaired readings were treated
as missing data and omitted from further analyses. For
illustrative purpose, 2 of the 10 time series plots are shown in
Figure 1, representing the strongest and weakest measures of
intraclass correlation.
The graphical comparison of aggregated epochs in Figure 2
shows how heart rate measures from Fitbit were consistently
lower than Polar, whereas the width of 10-s Polar value ranges
remained consistent.
Table 2 shows the ICCs and differences between Fitbit and
Polar measures. The overall ICC between both devices was
strong (.83; 95% CI 0.63-0.91) and ranged from .40 to .97 across
participants. The ICC was markedly weaker at MVPA heart
rate zones as compared with the low heart rate zone. On average,
Fitbit devices measured heart rates that were −5.96 bpm (95%
CI −6.33 to −5.60) lower than Polar. Reviewing the differences
between participants, we noted that the underestimate was
statistically significant in all but 1 participant, who also
demonstrated the strongest ICC. Again, the difference between
both devices was greater in MVPA heart rate zones. This finding
was reproduced in the Bland-Altman plots of measures (Figure
3).
Figure 2. Box-plots providing by-decile comparisons of average Polar (dark gray) and Fitbit (black) measures, width of within-epoch ranges of 10-second
Polar measures (white) included (n=2509).
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Table 2. Overall and stratified comparisons between Fitbit and Polar of minute-by-minute epochs.
Within-epoch comparison of 1-min Fitbit and average 10-s Polar







<.001−5.96 (−6.33 to −5.60).83 (0.63-0.91)2509Overall
By Centers for Disease Control and Prevention heart rate zonec
<.001−4.24 (−4.53 to −3.96).77 (0.55-0.87)2146Low (<50%)
<.001−16.2 (−17.6 to −14.7).56 (0-0.79)363Moderate to vigorous physical activity (≥50%)
By participant
<.001−2.58 (−2.99 to −2.18).87 (0.69-0.94)348A
<.001−3.92 (−4.55 to −3.29).75 (0.50-0.86)358B
<.001−5.08 (−6.01 to −4.14).70 (0.28-0.85)169C
.700.25 (−1.08 to 1.58).97 (0.96-0.98)198D
<.001−6.40 (−7.13 to −5.67).62 (0.14-0.81)359E
<.001−17.4 (−19.5 to −15.4).47 (0-0.74)208F
<.001−5.05 (−5.62 to −4.47).72 (0.19-0.88)320G
<.001−5.20 (−6.45 to −3.94).81 (0.65-0.88)228H
<.001−12.3 (−13.6 to −11.1).40 (0-0.68)248I
.02−0.92 (−1.69 to −0.14).93 (0.88-0.95)73J
aICCs derived using two-way mixed effects model for absolute agreement.
bStatistics derived in paired t tests.
cCalculated as percent of maximal heart rate (220 bpm—age in years) for discreet 1-min epochs drawing from the average 10-s Polar measure and age
of the respective participant.
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Figure 3. Bland-Altman plots for paired measures in low (top) and moderate to vigorous physical activity (MVPA; bottom) Centers for Disease Control
and Prevention (CDC) heart rate zones.
Within the aggregate 2509 1-min epochs shown in Table 3, only
363 were spent in the MVPA heart rate zone according to Polar
measures.
One-Month Continuous Observation
Figure 4 shows that wear time on valid days was consistent,
although the number of participants providing valid days of
device usage declined over the course of the study period.
On valid days of device usage as shown in Table 4, 24.4% of
epochs were classified as nonwear time, 71.7% of epochs fell
within the low intensity heart rate zone, and 3.9% of epochs
were classified as MVPA. Thus, on average, participants spent
55 min (SD 34) per day in the MVPA heart rate zone.
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Table 3. Number of 1-min epochs spent in Centers for Disease Control and Prevention (CDC) physical activity heart rate zone; n=2509 paired
observations. Sensitivity and specificity were 52.9% (192/363) and 98.6% (2115/2146), respectively. The positive predictive value for a 1-min epoch
categorized as MVPA by Fitbit values was 86.1% (192/223), and the negative predictive value was 92.52% (2115/2286).
Total, n (%)According to Fitbit values, n (%)Epoch categorization
MVPAaLow
According to average 10-s Polar values
2146 (100.0)31 (1.4)2115 (98.6)Low
363 (100.0)192 (52.9)171 (47.1)MVPA
aMVPA: moderate to vigorous physical activity.
Figure 4. Number of participants with valid days (gray bars) with distribution of aggregated wear time means (boxes) and one standard deviation
(whiskers).
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Table 4. Free-living data collection. Over n=270 valid person-days of Fitbit usage.
Average daily minutes spent
in MVPAb heart rate zone
Number of 1-min epochs spent in CDCa physical activity heart





55 (SD 34)14,951 (3.9)278,856 (71.7)94,993 (24.4)388,800270Overall
By participant
30631 (2.09)16,397 (54.2)13212 (43.7)30,24021A
471395 (3.2)29,729 (68.8)12076 (28.0)43,20030B
1062765 (7.4)20,691 (55.3)13984 (37.4)37,44026C
24784 (1.7)30,600(64.4)16136 (34.0)47,52033D
561240 (3.9)23,686 (74.8)6754 (21.3)31,68022E
561784 (3.9)33,593 (72.9)10703 (23.2)46,08032F
481637 (3.3)44,580 (91.1)2743 (5.6)48,96034G
23778 (1.6)45,488 (92.9)2694 (5.5)48,96034H
1233685 (8.5)27,614 (63.9)11901 (27.6)43,20030I
32252 (2.2)6478 (56.2)4790 (41.6)11,5208J
aCDC: Centers for Disease Control and Prevention.
bMVPA: moderate to vigorous physical activity.
Discussion
Principal Findings
In this free-living validation study, we have compiled rich data
by relatively convenient means, capturing 2509 1-min epochs
of paired data and tens of thousands of unpaired 1-min epochs
in the follow-up period. Visual inspection of within-participant
heart rate plots showed that there were differences in how well
Fitbit readings coincided with Polar ranges. We ascertained an
overall strong ICC for absolute agreement between Fitbit and
Polar measures that varied markedly between participants and
diminished at heart rates that represent moderate to vigorous
intensity physical activity. The Fitbit devices identified just over
half of MVPA heart rate zone readings correctly.
Our summary measure of a 6 bpm or 7% underestimate of heart
rates measured by Fitbit was in keeping with current literature
where error estimates have been established under laboratory
conditions [18,26,27]. In MVPA heart rate zones, we found an
average underestimate of 16 bpm, which was shown to markedly
impact Fitbit’s ability to correctly identify time spent in MVPA
under free-living conditions. This finding of a larger error at
higher heart rates is consistent with other studies [26,28].
However, our findings suggest that the systematic
underestimation of heart rates might partially be accounted for
by differences between participants.
Applying our own measures of sensitivity and specificity to the
data obtained during the 1-month follow-up period, we could
surmise that close to an hour’s worth of MVPA epochs were
not captured on any given day. This underestimate of daily
MVPA time contrasts with the overestimate observed in a
free-living validation study of a wrist-worn tracker of the same
brand that measured bouts of activity based on accelerometry
[29]. It is also important to note that Fitbit wear time and the
number of participants wearing it sufficiently long had decreased
considerably even over the 1-month monitoring period. This is
consistent with findings from other studies [30] that have also
reported considerable drops in compliance with wearable device
use over time.
Our free-living validation study into the accuracy of wrist-worn
heart rate monitors has several implications on their potential
usefulness in monitoring relevant physiological parameters over
time and tracking compliance with exercise prescriptions. The
results are in keeping with the past studies, which concluded
that the device would fare poorly in the calibration of intensity
of activity owing to insufficient accuracy. Concerning activity
tracking, we found that the devices would fail to recognize one
in two MVPA heart rate zone epochs, thus diminishing their
value as a means of assessing activity levels objectively. Our
follow-up data suggest that device use declined over the course
of the study, further complicating potential uses as a compliance
monitoring tool.
Overall, our findings have demonstrated that more emphasis
should be placed on eliminating systematic error in the tracker
measures. Our data showed that errors might be explained in
part by putative between-participant differences that would
include device fit and skin surface characteristics. Additional
mathematical calibration might be appropriate for the trackers
to more reliably detect MVPA heart rate zones. As these sensors
become increasingly ubiquitous, their potential role in exercise
prescription and health promotion merits further evaluation.
Limitations
Our study design was limited to a small sample of mostly male,
young adults who did not report significant health issues, thus
limiting the generalizability of our findings. The recruitment of
female participants was affected by expressed discomfort
wearing the Polar H6 chest strap beneath undergarments. In
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addition, the measurement period was restricted over a few
hours of one day where participants would engage in their
normal activities. Although this provided us the necessary
information on usual day-to-day life, it resulted in a limited
number of paired measures, particularly in the moderate to
vigorous heart rate zones. We did not include any form of
activity diary in the 1-month period of follow-up, thus limiting
our ability to verify the total duration of MVPA accrued. The
sensitivity of the photoplethysmographic probe is strongly
affected by placement and skin condition [10]. Although we
provided advice on proper fit, it is plausible that participants
may have foregone scientific accuracy in favor of personal
comfort by loosening wrist straps. Due to the logistics of the
study, we were unable to ascertain proper fit at the end of the
observation period, which could have provided further insights
into the apparent interpersonal differences in Fitbit accuracy.
Finally, it is important to note that the optical sensors provide
a measure of microvascular perfusion, whereas our reference
device registers myocardial electric potentials. In practice the
arterial pulse rate is often synonymous with the rate of cardiac
contractions, but this level of equivalence might be considered
inappropriate in the evaluation of photoplethysmographic
devices, which are known to be affected by movement and other
artifacts that contribute to error rates of up to 8% [10].
Conclusions
The nature of this study was part validation and part exploration.
While the overall ICC for absolute agreement appears strong,
our data suggest that under free-living conditions, Fitbit Charge
HR trackers overall compared poorly against the reference
device, especially at higher heart rate zones. Our findings are
in line with findings of past studies, which have expressed
concern that such devices might not provide adequate
information to guide exercise intensity or detect MVPA. Given
the nature of our small pilot study with a limited period of
observation, further research with a larger sample is warranted
to confirm our results.
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API: application programming interface
CDC: Centers for Disease Control and Prevention
ICC: intraclass correlation coefficient
MVPA: moderate to vigorous physical activity
SD: standard deviation
SE: standard error
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